Significance of cross-talk among ADP, thromboxane A2 and collagen during collagen-induced thrombus formation

胶原诱导血栓形成过程中 ADP、血栓素 A2 和胶原之间串扰的意义

基本信息

  • 批准号:
    17580258
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

Collagen is the most important platelet activator. It secretes ADP from platelet dense granules and thromboxane A2 (TXA_2) following activation of arachidonic acid cascade. ADP and TXA_2 in turn potentiate the action of collagen. However, detailed mechanism for synergism among collagen, ADP and TXA_2 is not fully elucidated. In this study, we investigated the synergism produced by these activators using bovine and rat platelets. Main findings are as follows.1) U46619, an active analog of TXA_2, did not cause aggregation by itself, but when combined with ADP at a sub threshold concentration, they caused considerable aggregation. Combination of ADP and U46619 synergistically elevated [Ca^<2+>]i. ADP P2Y1 receptor rather than P2Y12 receptor was though to be involved in the increase in [Ca^<2+>]i and aggregation produced 3y combination of ADP and U46619.2) Collagen and ADP also potentiated the aggregation. Activation of integrin a2pi, one of collagen receptor, by ADP may be responsible for the potentiation.3) No synergism was observed between U46619 (TXA_2) and collagen.4) In platelets from cattle or rats with Chediak-Higashi syndrome (CHS), dense granules are poorly developed, thereby ADP secretion was extremely inhibited in these platelets. Decreased secretion of ADP leads to impaired crosstalk between ADP or TXA_2 and that between ADP and collagen, resulting in decreased aggregation response, However, P-selectin release from a-granules was normal in platelets form cattle and rats with CHS.In human platelets it has been reported that ADP synergizes with TXA_2 through P2Y12 receptor, i.e. probably the PI3 kinase - Akt pathway is involved. In contrast, our data suggest that synergism between ADP and TXA_2 is mainly mediated through P2Y1 receptor in bovine platelets. Ca^<2+> may be important for the synergism. Thus, it seems that the mechanism involved in the crosstalk between platelet agonists is different depending on animal species.
胶原蛋白是最重要的血小板激活剂。它从血小板cascade激活后,从血小板致密颗粒和血栓烷A2(TXA_2)中分泌ADP。 ADP和TXA_2依次增强了胶原蛋白的作用。但是,胶原蛋白,ADP和TXA_2之间协同作用的详细机制尚未完全阐明。在这项研究中,我们使用牛和大鼠血小板研究了这些激活剂产生的协同作用。主要发现如下。1)U46619是TXA_2的活动类似物,并未单独引起聚集,但是当在子阈值浓度下与ADP结合时,它们会导致相当大的聚集。 ADP和U46619协同升高[Ca^<2+>] i的组合。 ADP P2Y1受体而不是P2Y12受体与[Ca^<2+>] I的增加有关,而聚集产生了ADP和U46619.2的3Y组合,并且ADP也增强了聚集。通过ADP,整合素A2PI(胶原蛋白受体之一)的激活可能是负责增强的。3)在牛或Chediak-Higashi综合征(CHS)的牛或老鼠中,在牛或老鼠中,在U46619(TXA_2)和胶原蛋白之间未观察到任何协同作用。 ADP的分泌减少会导致ADP或TXA_2之间的串扰受损,而ADP和胶原蛋白之间的串扰,导致聚集反应降低,但是,从A颗粒中释放了P-选择蛋白在血小板中正常释放在血小板中是牛形成牛的,并用CHS.IN人体血小板形成牛和大鼠。 AKT途径涉及。相反,我们的数据表明,ADP和TXA_2之间的协同作用主要是通过牛血小板中的P2Y1受体介导的。 Ca^<2+>对于协同作用可能很重要。因此,似乎血小板激动剂之间串扰的机制取决于动物物种。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Alteration of release and roles of ADP and thromboxane A_2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome
Chediak-Higashi 综合征牛胶原诱导血小板聚集过程中 ADP 和血栓素 A_2 的释放和作用的改变
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Honda N;Ohnishi K;Fujishiro T;Ikeda M;Ito K
  • 通讯作者:
    Ito K
Chediak-Higashi症候群における血小板凝集異常
Chediak-Higashi 综合征中的血小板聚集异常
Platelet dysfunction accompanied with Chediak-Higashi syndrome (in Japanese, review)
伴有 Chediak-Higashi 综合征的血小板功能障碍(日语,综述)
Impairment of endothelium-dependent relaxation of aortas and pulmonary arteries from spontaneously hyperlipidemic mice (Apodemus sylvaticus)
  • DOI:
    10.1016/j.vph.2007.06.001
  • 发表时间:
    2007-08-01
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Ito, Kaoru M.;Okayasu, Misao;Ito, Katsuaki
  • 通讯作者:
    Ito, Katsuaki
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ITO Katsuaki其他文献

ITO Katsuaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ITO Katsuaki', 18)}}的其他基金

The role of P2X receptor in overactive bladder and application of drugs targeting the receptor
P2X受体在膀胱过度活动症中的作用及靶向药物的应用
  • 批准号:
    21580365
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on the signal transduction system of platelet collagen receptor that is related to species difference of hemostasis
与止血种属差异相关的血小板胶原受体信号转导系统的研究
  • 批准号:
    15580261
  • 财政年份:
    2003
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characteristics of aggregation of bovine platelets and clarification of molecular mechanism responsible for a genetic hemorrhagic disease in cattle
牛血小板聚集特征及牛遗传性出血病分子机制的阐明
  • 批准号:
    12660272
  • 财政年份:
    2000
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Biological significance of palytoxin-sensitive ion channel associated with NaィイD1+ィエD1,KィイD1+ィエD1-ATPase molecule
NaiiD1+IeD1、KiiD1+IeD1-ATPase分子相关的海藻毒素敏感离子通道的生物学意义
  • 批准号:
    09460140
  • 财政年份:
    1997
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Role of protein tyrosine kinase in functional changes of hyperplastic arteries
蛋白酪氨酸激酶在增生性动脉功能变化中的作用
  • 批准号:
    07660404
  • 财政年份:
    1995
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of plasmalemmal Ca^<2+> channels and intracellular Ca^<2+> stores in vascular smooth muscles during the development of vascular resistance
血管平滑肌质膜Ca^2通道和细胞内Ca^2储存在血管阻力发展过程中的作用
  • 批准号:
    04660325
  • 财政年份:
    1992
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Cellular calcium movements and the role in regulating contraction and relaxation of vascular smooth muscles of resistance vessels
细胞钙运动及其调节阻力血管平滑肌收缩和舒张的作用
  • 批准号:
    02660312
  • 财政年份:
    1990
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Studies on the alterations of lung endothelial cells and the metabolism of autacoids during lung diseases
肺部疾病过程中肺内皮细胞变化及自体物质代谢的研究
  • 批准号:
    60480095
  • 财政年份:
    1985
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似国自然基金

口腔黏膜下纤维性变中赖氨酸羟化酶2异常活化抑制胶原降解的机制研究
  • 批准号:
    82301102
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
血小板源PDGFB重塑胶原改变应力微环境促进脑胶质瘤恶性进展的机制研究
  • 批准号:
    82303425
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
胶原自组装多孔膜的结构调控机制及其在氨基酸发酵提取中的应用研究
  • 批准号:
    22378160
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
Ⅲ型胶原介导脑出血恢复期胶质瘢痕形成的作用及机制研究
  • 批准号:
    82371322
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
CCL21低表达抑制CCR7+Mφ分化参与子宫腺肌病内膜胶原沉积的机制研究
  • 批准号:
    82371678
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Targeting the Thromboinflammatory Response to Mitigate Bowel Injury in Necrotizing Enterocolitis
靶向血栓炎症反应以减轻坏死性小肠结肠炎的肠道损伤
  • 批准号:
    10840235
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
The MICELI Aggregometer: a Point-of-Care Platelet Function Analyzer
MICELI 聚合仪:即时血小板功能分析仪
  • 批准号:
    10011463
  • 财政年份:
    2020
  • 资助金额:
    $ 2.3万
  • 项目类别:
Rap1 signaling in platelet homeostasis and vascular hemostasis
Rap1 信号在血小板稳态和血管止血中的作用
  • 批准号:
    9330204
  • 财政年份:
    2016
  • 资助金额:
    $ 2.3万
  • 项目类别:
Smoking cessation affects human platelet activation
戒烟影响人体血小板活化
  • 批准号:
    16K20089
  • 财政年份:
    2016
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Novel strategies to prevent FcgRIIA-dependent platelet activation and thrombosis
预防 FcgRIIA 依赖性血小板活化和血栓形成的新策略
  • 批准号:
    8501660
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了